PubMed

Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia.

Cheng CH, Sanders GD, Hlatky MA, Heidenreich P, McDonald KM, Lee BK, Larson MS, Owens DK.

Ann Intern Med. 2000 Dec 5;133(11):864-76. Erratum in: Ann Intern Med 2001 Nov 20;135(10):933. PMID: 11103056 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of radiofrequency catheter ablation versus medical treatment for paroxysmal supraventricular tachycardia in Japan.

Ikeda T, Sugi K, Enjoji Y, Kasao M, Abe R, Ninomiya K, Yabuki S, Yamaguchi T.

J Cardiol. 1994 Nov-Dec;24(6):461-8.PMID: 7823285 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of radiofrequency catheter ablation in the treatment of symptomatic supraventricular tachyarrhythmias.

Kertes PJ, Kalman JM, Tonkin AM.

Aust N Z J Med. 1993 Aug;23(4):433-6.PMID: 8240167 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation.

Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ.

Circ Arrhythm Electrophysiol. 2009 Aug;2(4):362-9. Epub 2009 Apr 17.PMID: 19808491 [PubMed - indexed for MEDLINE]Related articlesFree article

Radiofrequency catheter ablation of supraventricular tachycardia in children and adolescents : feasibility and cost-effectiveness in a low-income country.

Vida VL, Calvimontes GS, Macs MO, Aparicio P, Barnoya J, Castañeda AR.

Pediatr Cardiol. 2006 Jul-Aug;27(4):434-9. Epub 2006 Jul 6.PMID: 16830085 [PubMed - indexed for MEDLINE]Related articles

Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs.

Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM.

Am J Cardiol. 1998 Sep 1;82(5):589-93.PMID: 9732885 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation.

Catherwood E, Fitzpatrick WD, Greenberg ML, Holzberger PT, Malenka DJ, Gerling BR, Birkmeyer JD.

Ann Intern Med. 1999 Apr 20;130(8):625-36.PMID: 10215558 [PubMed - indexed for MEDLINE]Related articlesFree article

Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.

Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK.

Ann Intern Med. 2001 Nov 20;135(10):870-83.PMID: 11712877 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome.

Hogenhuis W, Stevens SK, Wang P, Wong JB, Manolis AS, Estes NA 3rd, Pauker SG.

Circulation. 1993 Nov;88(5 Pt 2):II437-46.PMID: 8222191 [PubMed - indexed for MEDLINE]Related articles

Radiofrequency catheter ablation in the treatment of supraventricular tachycardia in the elderly.

Epstein LM, Chiesa N, Wong MN, Lee RJ, Griffin JC, Scheinman MM, Lesh MD.

J Am Coll Cardiol. 1994 May;23(6):1356-62.PMID: 8176093 [PubMed - indexed for MEDLINE]Related articles

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French. PMID: 15959450 [PubMed - indexed for MEDLINE]Related articles

Long-term follow-up of patients treated by radiofrequency ablation of the atrioventricular junction.

Jensen SM, Bergfeldt L, Rosenqvist M.

Pacing Clin Electrophysiol. 1995 Sep;18(9 Pt 1):1609-14.PMID: 7491304 [PubMed - indexed for MEDLINE]Related articles

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.PMID: 16904046 [PubMed - indexed for MEDLINE]Related articlesFree article

Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.

Gazelle GS, McMahon PM, Beinfeld MT, Halpern EF, Weinstein MC.

Radiology. 2004 Dec;233(3):729-39.PMID: 15564408 [PubMed - indexed for MEDLINE]Related articlesFree article

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.PMID: 17999840 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.

Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA.

Ann Intern Med. 1997 Jan 1;126(1):1-12.PMID: 8992917 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of lopinavir/ritonavir compared with atazanavir in antiretroviral-naive patients: modelling the combined effects of HIV and heart disease.

Simpson KN, Luo MP, Chumney EC, King MS, Brun S.

Clin Drug Investig. 2007;27(1):67-74.PMID: 17177581 [PubMed - indexed for MEDLINE]Related articles

Should radiofrequency therapy be performed in every symptomatic patient with supraventricular tachycardia? (Pro drug position).

Andresen D, Behrens S, Brüggemann T, Schröder R.

Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):653-7. Review.PMID: 7681971 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of treatment of supraventricular arrhythmias related to an accessory atrioventricular pathway: comparison of catheter ablation, surgical division and medical treatment.

Weerasooriya HR, Murdock CJ, Harris AH, Davis MJ.

Aust N Z J Med. 1994 Apr;24(2):161-7.PMID: 8042944 [PubMed - indexed for MEDLINE]Related articles

A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone.

Schleinitz MD, Heidenreich PA.

Ann Intern Med. 2005 Feb 15;142(4):251-9.PMID: 15710958 [PubMed - indexed for MEDLINE]Related articlesFree article